Hiroomi Tada
Chief Tech/Sci/R&D Officer at TYRA BIOSCIENCES, INC.
Net worth: 1 M $ as of 30/04/2024
Profile
Mr. Hiroomi Tada is a Chief Medical Officer at Tyra Biosciences, Inc. Mr. Tada was previously employed as an Executive Director by IQVIA, Inc., a Chief Medical Officer by Notable Labs, Inc., a Vice President-Translational Sciences by Target Therapeutics, Inc., an Assistant Professor by Temple University School of Medicine, and an Assistant Professor by UMass Chan Medical School.
He received his undergraduate degree from Haverford College, a doctorate degree from Sidney Kimmel Medical College and a doctorate degree from Thomas Jefferson University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC
0.16% | 26/03/2024 | 86,435 ( 0.16% ) | 1 M $ | 30/04/2024 |
Hiroomi Tada active positions
| Companies | Position | Start |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/11/2020 |
Former positions of Hiroomi Tada
| Companies | Position | End |
|---|---|---|
Notable Labs, Inc.
 Notable Labs, Inc. Hospital/Nursing ManagementHealth Services Notable Labs, Inc. provides personalized testing services for cancer patients. Its testing prioritizes combinations of FDA-approved treatments that can be prescribed by a doctor without a clinical trial. The company was founded by Peter Quinzio and Matthew De Silva in 2013 and is headquartered in Foster City, CA. | Chief Tech/Sci/R&D Officer | - |
| Temple University School of Medicine | Corporate Officer/Principal | - |
| IMS HEALTH, INC. | Director/Board Member | - |
| UMass Chan Medical School | Corporate Officer/Principal | - |
Target Therapeutics, Inc.
 Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Training of Hiroomi Tada
| Thomas Jefferson University | Doctorate Degree |
| Haverford College | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TYRA BIOSCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Target Therapeutics, Inc.
Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Health Technology |
IQVIA, Inc.
 IQVIA, Inc. Data Processing ServicesTechnology Services IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT. | Technology Services |
Notable Labs, Inc.
Notable Labs, Inc. Hospital/Nursing ManagementHealth Services Notable Labs, Inc. provides personalized testing services for cancer patients. Its testing prioritizes combinations of FDA-approved treatments that can be prescribed by a doctor without a clinical trial. The company was founded by Peter Quinzio and Matthew De Silva in 2013 and is headquartered in Foster City, CA. | Health Services |
- Stock Market
- Insiders
- Hiroomi Tada
